Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 30, 2020

SELL
$1.91 - $3.08 $136,792 - $220,586
-71,619 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$1.97 - $3.98 $56,688 - $114,528
28,776 Added 67.17%
71,619 $198,000
Q1 2020

May 11, 2020

SELL
$1.17 - $3.0 $58,194 - $149,217
-49,739 Reduced 53.72%
42,843 $129,000
Q4 2019

Feb 13, 2020

SELL
$1.16 - $1.42 $123,042 - $150,620
-106,071 Reduced 53.4%
92,582 $114,000
Q3 2019

Nov 08, 2019

BUY
$1.21 - $1.65 $240,370 - $327,777
198,653 New
198,653 $264,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.